https://www.apple.com/newsroom/2022/08/apple-and-mlb-announce-september-friday-night-baseball-doubleheader-schedule/
Verrica Pharmaceuticals Announces Presentation Of Lesion Clearance Data From An Ongoing Phase 2 Study Of VP-315 For The Treatment Of Basal Cell Carcinoma At The American Academy Of Dermatology 2023 Innovation Academy Meeting
Presentation highlights the antitumor response of VP-315 for the non-surgical treatment of Basal Cell Carcinoma (BCC) as determined by clinical and histological lesion clearance
There are approximately 3-4
